BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36793862)

  • 1. PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC.
    Kim DE; Shin SB; Kim CH; Kim YB; Oh HJ; Yim H
    Theranostics; 2023; 13(3):1198-1216. PubMed ID: 36793862
    [No Abstract]   [Full Text] [Related]  

  • 2. Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer.
    Shin SB; Jang HR; Xu R; Won JY; Yim H
    Oncogene; 2020 Jan; 39(4):767-785. PubMed ID: 31548612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1.
    Xu R; Lee YJ; Kim CH; Min GH; Kim YB; Park JW; Kim DH; Kim JH; Yim H
    J Exp Clin Cancer Res; 2023 Nov; 42(1):302. PubMed ID: 37968723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.
    Ferrarotto R; Goonatilake R; Yoo SY; Tong P; Giri U; Peng S; Minna J; Girard L; Wang Y; Wang L; Li L; Diao L; Peng DH; Gibbons DL; Glisson BS; Heymach JV; Wang J; Byers LA; Johnson FM
    Clin Cancer Res; 2016 Apr; 22(7):1674-1686. PubMed ID: 26597303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
    Wang B; Tang Z; Gong H; Zhu L; Liu X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
    Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
    Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis.
    Singh R; Peng S; Viswanath P; Sambandam V; Shen L; Rao X; Fang B; Wang J; Johnson FM
    EMBO Mol Med; 2019 May; 11(5):. PubMed ID: 31040125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.
    Risolino M; Mandia N; Iavarone F; Dardaei L; Longobardi E; Fernandez S; Talotta F; Bianchi F; Pisati F; Spaggiari L; Harter PN; Mittelbronn M; Schulte D; Incoronato M; Di Fiore PP; Blasi F; Verde P
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):E3775-84. PubMed ID: 25157139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ can stimulate the p(38)/β-catenin/PPARγ signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells).
    Lin LC; Hsu SL; Wu CL; Hsueh CM
    Clin Exp Metastasis; 2014 Dec; 31(8):881-95. PubMed ID: 25168821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway.
    Hu Y; Mu H; Yang Y
    Histol Histopathol; 2021 Aug; 36(8):869-877. PubMed ID: 34100557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
    Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
    Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling.
    He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z
    BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis.
    Shukla S; Sinha S; Khan S; Kumar S; Singh K; Mitra K; Maurya R; Meeran SM
    Sci Rep; 2016 Feb; 6():21860. PubMed ID: 26905250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.
    Wang DX; Zou YJ; Zhuang XB; Chen SX; Lin Y; Li WL; Lin JJ; Lin ZQ
    Acta Pharmacol Sin; 2017 Feb; 38(2):241-251. PubMed ID: 27890917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.